Singapore Pharmaceutical Market Outlook to 2022: Ken Research

The report titled “Singapore Pharmaceutical Market Outlook to 2022 - by Prescription & OTC Drugs and by Patented & Generic Drugs” covers aspects such as pharmaceutical market segment (by Prescription & OTC Drugs, by Patented & Generic Drugs), competitive landscape of major players in the Singapore pharmaceutical market including Haw Par Corporation, Beacon Pharmaceuticals, GSK, Singapore, Roche, Singapore, AstraZeneca, Singapore, Lonza, Singapore, Baxter, Singapore, Abbott, Singapore, MSD, Singapore, Sunward Pharmaceutical, Poli Medical, Union Chemicals and Pharmaceuticals Pte Ltd, Schwabe Pharma Asia Pacific Pte Ltd, and Chemical Company of Malaysia Berhad,. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore Pharmaceutical Market

Singapore Pharmaceutical market can be characterized by the presence of best-in-class infrastructure, integrated and advanced hubs for pharmaceutical manufacturing and research and access to regional markets and skilled workforce. Singapore Pharmaceutical market has registered an increase in the revenue during the period 2012-2017. Many leading biomedical companies such as AbbVie, Pfizer, Ferring Pharmaceuticals and others have selected Singapore as their global manufacturing base. Singapore pharmaceutical market has increased at a single digit CAGR during 2012-2017. Singapore has emerged as one of the most integrated and advanced hubs for pharmaceutical manufacturing and research in Southeast Asia. Singapore has developed 2 biomedical hubs namely Biopolis and Tuas Biomedical Park. Biopolis facilitates the cooperation between public sector research centers with private labs whereas the Tuas Biomedical Park is dedicated primarily to pharmaceutical manufacturing and production.

Singapore Pharmaceutical Market Segmentation

By Prescription & OTC Drugs: Prescription drugs have accounted for largest share of the revenue in Singapore pharmaceutical market in 2017. OTC drugs have accounted for the remaining share of the revenue. The growth in prescription drugs can be attributed to prevalence of chronic diseases such as diabetes, cancer and others have further driven prescription drugs sale. Sale of OTC drugs has been on an incline owing to rise in trend of self-medication in Singapore. Majority of antibiotics are sold via OTC channel. Vitamins and dietary supplements are one of the fastest growing segments of OTC

By Patented & Generic Drugs: Patented drugs have accounted for largest share of the revenue in Singapore prescription drugs market in 2017. Generic drugs have accounted for the remaining share in terms of revenues. The presence of secure IP protection has encouraged international companies to set up manufacturing facilities and gain patent rights for their drugs, API and production process. Further, it is supported by the availability of modern infrastructure and large investment in research activities. These include drugs for infectious diseases and oncology.

Singapore Over-The-Counter Drugs Market

Singapore OTC market increased at a double digit CAGR during 2012-2017. The market is driven by increasing number of people taking self-medication. Further, increased focus on R&D efforts has led to better focus on the advancement of innovative over-the-counter and consumer health drugs. Major therapeutic segments include antibiotics, analgesics and antacids. Since these medicines do not require a prescription, the manufacturers are also able to sell them through online retail channels. Leading companies in the OTC market include GlaxoSmithKline Plc, Reckitt Benckiser Group Plc (RB), Ricola AG, Lofthouse of Fleetwood Ltd, Haw Par Corp Ltd and Valeant Pharmaceuticals International Inc

Singapore Pharmaceutical Market Competition Overview

The market is fragmented with multinational companies dominating the space with major focus on research & development activities. There are 54 pharmaceutical manufacturers and 5,500 registered medicines as of 2017. Major multinational companies include GSK, Novartis, Roche, Pfizer, Bayer, AstraZeneca, Abbott, Baxter, Maccine and others. The pharmaceutical market has witnessed increasing advancement of innovative over-the-counter, generic, prescription and consumer health drugs. Major competition parameters include product range, distribution network, technology, investment in R&D

Singapore Pharmaceutical Market Future Potential

Singapore pharmaceutical market is expected to grow at a single digit CAGR during 2017-2018 driven by universal access to health insurance and world-class biomedical research facilities.

The best in class research and manufacturing infrastructure will continue to attract foreign investment in the country. For instance, Japan’s Chugai Pharmaceutical, which operates satellite labs throughout Asia, has plans to invest USD 355 million by 2021, to accelerate its research and development (R&D) capabilities in Singapore. The industry will witness a rise in development of technology to support automation and increase productivity. For instance, GSK has been pioneering a technology called continuous manufacturing where instead of making products in batches, materials are constantly added and products removed. Big global drug makers ramp up output and advance automation at their production sites across the country.  

Key Topics Covered in the Report:

·         Singapore Pharmaceutical Market Size, 2012-2017

·         Singapore Pharmaceutical Market Segmentation (by Prescription & OTC Drugs, by Patented & Generic Drugs)

·         Singapore Over-The-Counter Market Size

·         Trends and Developments in Singapore Pharmaceutical Market

·         Issues and Challenges in Singapore Pharmaceutical Market

·         Government Initiatives, Rules and Regulations in Singapore Pharmaceutical Market

·         Singapore Pharmaceutical Market Competitive Landscape

·         Singapore Pharmaceutical Future Outlook and Projections, 2018-2022

·         Value Chain in Singapore Pharmaceutical Industry

·         Analyst Recommendations

For more information on the research report, refer to below link:

https://www.kenresearch.com/healthcare/pharmaceuticals/singapore-pharmaceutical-market/149668-91.html

Related Reports by Ken Research

https://www.kenresearch.com/healthcare/pharmaceuticals/vietnam-pharmaceutical-market/143605-91.html

Currently all patented drugs are imported for local consumption. Widely imported patented drugs include high-value specialty drugs for oncology and diabetes management.

https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmaceutical-market/143542-91.html

Majority pharmaceutical companies are located in West Java and Jakarta due to favorable tax incentives, well developed infrastructure and greater access to medicinal herbs.

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Awareness in Oral and Dental Health Benefits to Boost Asia Chewing Gum Base (CAS 70892-12-5) Industry-Ken Research

Asia Chewing Gum Base Market consists of both regional and international vendors such as Boc Sciences, Wacker, Dalian Haiyi International Cooperation Co., Ltd, Haihang Industry Co., Ltd., Neostar United Industrial Co., Ltd., Angene International Limited, Zhejiang J&C Biological Technology Co.,Limited and Wuxi Liujinji Gumbase Co., Ltd. Almost all the chewing gum base products are available at hypermarket, supermarkets, convenience stores and drugstores. These outlets account for a major share in revenue contributor of the chewing gum base market. Asia’s chewing gum base market anticipates a moderate growth over the next few years due to consumers’ awareness in oral and dental health benefits of sugar-free chewing gums.

Gum base is an ingredient that differentiates between chewing gum and bubble gum from all other confectionery products. Gum base is an insoluble and non-nutritive substance that enables chewing gum to be chewed without experiencing any substantial changes. Gum base is made of food-grade polymers, plasticizers, softeners, texturizers and emulsifiers which impart their unique properties in a chewing gum. To meet the international food-grade standards, the gum base needs to comply with requirements such as the FDA 21 CFR 172.615 and the Food Chemicals Codex Specifications. Every new gum base that is developed is tested for its physical properties such as elasticity, plasticity, hardness and desired texture. Gum bases for bubble and chewing gums are available in various formats such as dragées, sticks, tabs, chunks, hollow balls, filled gum and others. There are many types of bubble and chewing gums which utilize more than 200 different kinds of gum bases in the manufacturing process. The gum base depends on manufacture of bubble or chewing gum, with sugar or sugar-free, including acid or non-acid flavours, formats and production of chewing gum for the confectionery, functional or pharmaceutical market.

Modern chewing gum is a soft, cohesive substance that cannot be swallowed. Chewing gums with gum base consist of texture that signifies rubber due to its physical-chemical properties of polymer, plasticizer, and resin components that contribute elasticity-plastic, stickiness and chewy characteristics. Elastomers are responsible for the stretchy and sticky nature in a chewing gum. Plasticizers improve flexibility and reduce brittleness that contributes to the plastic and elastic nature in a chewing gum. Chewing gum is water in-soluble and cannot be consumed fully. Chewing gum is the second most common form of litter after cigarette litter. It was observed that chewing gum litter was collected and recycled into plastic in various regions worldwide.

International Chewing Gum Association (ICGA) says that chewing sugar-free gum increases saliva production in a human body that reduces instances of plaque formation and tooth decay significantly. Consuming sugar-free chewing gum helps in cleaning food debris from the teeth and reduces stress. However, chewing gum products like nicotine gum are considered as effective aids to quit smoking. Chewing gum base is categorized based on product ingredients such as sugared and sugar-free. It is estimated that sugar-free chewing gums will dominate the chewing gum market over the next few years. Sugar-free chewing gums base possess benefits such as ability to re-mineralize the enamel, neutralize plaque acids, reduce instances of oral dryness, and clean food remains.

To know more, click on the link below:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-chewing-gum-base-cas-70892-12-5-industry-situation-and-prospects-research-report/145727-101.html

Related Reports:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/north-america-chewing-gum-base-cas-70892-12-5-industry-situation-and-prospects-research-report/146405-101.html

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/china-chewing-gum-base-cas-70892-12-5-industry-situation-and-prospects-research-report/146237-101.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Disaster Logistics Management Market Outlook: Ken Research

Disaster logistics is defined as management of relief material to be delivered to the affected people and area in times of disaster. Many severe disasters have taken place in recent years and disaster management has been a global concern for years. Disaster logistics business review shows that there is a need to mobilize resources and expertise in an efficient manner.

Disaster management for years was seen on a single level but now logistics and transportation market research reports consulting has led to a more broad view in which disaster logistics have been stratified. For the last few years the Federal Emergency Management Agency (FEMA) has been testing technologies to improve disaster logistics. The goal of this is to combine the technologies to develop a system which would have the following functions:

Resource management which will be an automated database of the human and physical resources responding to the disaster including warehousing/inventory management

Planning through a library of Emergency Response Plans that can be selected, activated and easily managed in times of crisis

Incident Management through a system designed with the user in mind to facilitate workflow of any emergency agency.

Operations Command and Control through   geo-spatial mapping for actual/live responses as well as disaster logistics asset tracking.

Transportation and Shipping of relief material like medicines, food supplies and water from origination to destination with tracking via GPS transponders.

Simulation/Drill Exercise Automation to better prepare people and authorities to deal with crisis.

Other agencies like Emergency Management Assistance Compact (EMAC) have offered small regions assistance. EMAC provides a responsive and straightforward system for US states to send personnel and equipment to help disaster relief efforts in other states. Despite this sometimes the disaster scenario is overwhelming and so many emergency agencies are turning towards the private sector partners for supplies and equipment. Big companies like Walmart also undertake efforts to assist as they have developed their logistics sector to distribute relief supplies to communities in need immediately after a disaster takes place.

The US is a great example of developments in disaster logistics and has shown the strength of community effort. This is evident by the fact that 22 out of the top 50 retailers in the US aid the EMAC by directly supplying resources. This also brings out the fact that disaster logistics must have a comprehensive Supplier Management that allows the retail community to receive and fulfill orders for needed supplies and equipment. Warehousing also plays a crucial role in keeping relief supplies safe. World Vision has 11 warehouses of donated goods in the US alone and represents a vital source of needed supplies and equipment to the emergency management community.

Disaster logistics is a growing sector that has immense potential for future growth as well. The US clearly displays the benefits of community building that will augment disaster logistics development. The mobilization of resources and proper information system are the key to success in the field. Organizations that receive assistance from private players are expected to be the growth drivers.

Key Factors Considered in the Report:

Logistics and Shipping Market Research Reports

Logistics and Shipping Industry Analysis

Market Research Reports for Logistics

Logistic Market Research Report

Logistics and Transportation Market Research Reports Consulting

Logistics Business Review

Logistics and Shipping Industry Research and Market Reports

To know more, click on the link below:

https://www.kenresearch.com/automotive-transportation-and-warehousing/logistics-and-shipping/SC-100-45.html

Contact Us:

Ken Research 

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Singapore Medical Device Market is Expected to Reach SGD 1.6 Billion by 2022: Ken Research

Ken Research in its latest study, “Singapore Medical Devices Market Outlook to 2022 - by Type of Medical Device (Consumables, Diagnostic Imaging, Patient Aids, Orthopedic & Prosthetics, Dental Products and Others)”, suggests that demand for medical devices in the market will continue to grow in Singapore owing to technology advancements and rising number of hospitals and other healthcare facilities.

·         The medical device market is dominated by foreign manufacturers which supply more than 85.0% of the medical devices in the country. Leading importers include the US, Germany and Japan. Furthermore, more than 60% of products imported into Singapore are subsequently re-exported.

·         The Ministry of Health is the leading end user of medical devices which procures medical devices through tender process. MOH follows the Price-Quality Method (PQM) to evaluate tender proposals.

The medical device market will incline at a healthy growth rate driven by growing investment in public and private health care sector and emphasis on local production. In 2017, Singaporean medical device regulators implemented a new priority market pathway that could reduce review timeframes for qualifying medical devices by up to 35% within two years. Health Sciences Authority, Singapore anticipates that the priority review scheme will reduce turnaround times for premarket reviews for the full evaluation routes by 25% by mid-2018, and by 35% by late 2019. Evaluation fees for the HSA priority review scheme are set to increase 15% over current rates for route 1, while fees for full HSA reviews route 2 will increase 50% over existing rates. This will allow manufacturers, importers and distributors to increase their revenue by introducing new and advanced medical devices in the market.

Digitalization is a key trend in healthcare with the electronic patient record in place and improving communication systems being considered. Telehealth and remote monitoring are being trialed for future implementation. There is also a shift from treatment to preventive care and health promotion, where mobile applications and wearable devices or the Internet of Things will see an increased uptake. Companies with medical solutions catered towards functional ageing will be able to tap on the Centre for Healthcare Innovation and Medical Engineering (CHIME) and the Silver Community Test-bed Programme launched by Singapore’s government to launch and test-bed age-friendly assistive devices in a real-life home setting.

Growing demand for home-use medical devices, expansion of healthcare facilities coupled with rising prevalence of lifestyle and chronic diseases will propel the Singapore medical device market revenue in future.

Companies Covered:

QT Vascular, Biosensors International, Becton Dickinson, Optimal Medical Products Pte Ltd, B. Braun Singapore Pte Ltd, Alcare Pharmaceuticals, and Kingston Medical Supplies Pte Ltd

To know more, click on the link below:

https://www.kenresearch.com/healthcare/medical-devices/singapore-medical-equipment-market/149667-91.html

Related Report  : -

https://www.kenresearch.com/healthcare/general-healthcare/uae-healthcare-market-report/37505-91.html

https://www.kenresearch.com/healthcare/general-healthcare/qatar-healthcare-market-report/99730-91.html

https://www.kenresearch.com/healthcare/general-healthcare/saudi-arabia-healthcare-market-research-report/1106-91.html

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Demand for Powder Metallurgy Manufactured Components to Boost Asia Chrome Plated Metal Powder Industry: Ken Research

Chrome plating is a technique of electroplating a thin layer of chromium on any metal object for decoration, corrosion resistance, cleaning procedures, and or to increase surface hardness. Chrome plating process comprises of degreasing to remove heavy soiling, manual cleaning to remove all residual traces of dirt and surface impurities, application of various pre-treatments depending on the substrate, chrome metal is allowed to warm to solution temperature for any application at a required time to attain desired thickness. The chrome plating process is a very toxic procedure and disposal of used chemicals is regulated to avoid environment pollution. Chrome plated metal powder market has varied applications in aerospace, electronics, welding material and alloys. Aerospace is the largest consumer of chrome plated metal powder. Electronics and welding segment is expected to grow due to improved lifestyles and increase in the disposable incomes of the Asian population in both developed and developing economies. The electronics segment is the major users of chrome plated metal powder and is expected to witness the highest growth over the next few years.

According to the research report “Asia Chrome Plated Metal Powder Industry Situation and Prospects Research Report”, it was observed that there is an intense competition in the chrome plated metal powder market due to the presence of large number vendors. Mergers, acquisitions, investments, and expansions are the major strategies adopted by vendors to ensure growth in the chrome plated metal powder market. The leading vendors in Asia’s chrome plated metal powder market are DELACHAUX Group, EXO Tech, POLEMA, GFE, MidUral Group, Global Metal Powders, Bell Group, Kohsei, Hascor, TRITRUST INDUSTRIAL, Loudishi Dajin Xincailiao, Zegen Metals&Chemicals Limited, Jayesh Group, Shanghai CNPC Powder Material, Jinzhou New Century Quartz and Jayu Optical Material. Metal chromium powder and electrolytic chromium powder are the two variants available in the chrome plated metal powder market. Geographically, Asia’s chrome plated metal powder market is spread across China, Japan, India, Korea, Saudi Arabia and other regions.

Chrome plated metal powder market is highly matured in Asia due to increasing disposable incomes, increasing consumption and demand for value-added sustainable products. It was observed that there is a growing demand for sustainable products, innovative production and advanced manufacturing technologies due to the need for reducing the environmental impact of the metal industry. The increase in demand for powder metallurgy manufactured components will witness a steady growth in Asia chrome plated metal powder market over the next few years.

To know more, click on the link below:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-chrome-plated-metal-powder-industry-situation-and-prospects-research-report/145733-101.html

Related Reports:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/china-chrome-plated-metal-powder-industry-situation-and-prospects-research-report/146243-101.html

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/global-chrome-plated-metal-powder-industry-situation-and-prospects-research-report/146075-101.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Industrialization and Modernization to Drive Asia’s Bicomponent Fiber Industry: Ken Research

Bicomponent fibers are defined as extruding two polymers from the same spinneret with both polymers contained within the same filament. Bicomponent fibers were first introduced by Dupont in the mid 1960s. The then bio component fiber was a side-by-side hosiery yarn known as cantrese which was made from two nylon polymers. In the 1970s, various bicomponent fibers were manufactures in Asia, notably in Japan. A very complex and expensive spin packs were apparently used in the manufacturing of biocomponent fibers. However, the techniques were technically unsatisfactory and excessively expensive. In 1989, biocomponent fiber was developed using thin flat plates with holes and grooves to route the polymers which was very flexible and quite price effective process.

According to the study “Asia Bicomponent Fiber Industry Situation and Prospects Research report”, with the introduction of biocomponent fibers, the textile industry is witnessing a drastic growth from the past decades. Textiles are not meant only for satisfying the basic needs of human, but also aids and enhances the human performance and comfort. Bicomponent fibers are most commonly utilized in medical textiles, geotextiles, package textiles, industrial textiles, automotive textiles, protective textiles and other forms of textiles. With the introduction of new variants in biocomponent fibres and new manufacturing processes for yarn and fabrics, the applications of technical textiles are increasing with varying consumer’s requirements. Bicomponent fibers provide thermal bonding, self bulking, very fine fibers, unique cross sections and are available at reduced cost. The various advantages of bicomponent thermal binder fibers are uniform distribution of adhesive, fiber remains a part of structure and adds integrity, customized sheath materials to bond various materials, wide range of bonding temperatures, cleaner, environmentally friendly, recyclable, lamination and moulding.

Bicomponent fibers are manufactured with any cross sectional shape or geometry that can be imagined. All the available bicomponent fibers are classified by their fiber cross-section structures as side-by-side, sheath-core, islands-in-the-sea and citrus fibers or segmented-pie cross-section types. Geographically, Asia bicomponent fiber industry is spread across China, Japan, South Korea. Taiwan, India and Australia Major vendors in Asia bicomponent fiber market are Toray Industries, Owens Corning, Teijin, Toho Tenax, Dupont, Eastman, JNC corp., CHA Technologies Group, ES FiberVisions, Far Eastern New Century, Huvis Corporation and Jiangsu Jiangnan High Polymer Fiber Co. Almost all variants of biocomponent fibers are used for various applications such as hygiene, textiles, automotive, home furnish and others. Now-a-days, bicomponent fibers are made of polymers which is an important material in the non-woven market. The main applications of biococmponent fibers are non-woven fabrics for diapers, feminine care and adult incontinence products (as top sheet, back sheet, leg cuffs, elastic waistband, transfer layers), air-laid nonwoven structures are used as absorbent cores in wet wipes and spun laced nonwoven products like medical disposable textiles, filtration products.

Within Asia, Japan and Korea account for the largest production of bicomponent fibers annually. The production of bicomponent fibers is a part of manmade fiber market and the manufacturers are confident about a significant growth in the next few years. Asian countries are the major consumers of biocomponet fibers due to the developing economies, increase in consumers’ disposal income, industrialization and modernization. With the increasing demand for finer fibers and fabrics, Asia bicomponent fiber industry will witness a drastic growth over the next few years.

To know more, click on the link below:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-bicomponent-fiber-industry-situation-and-prospects-research-report/145702-101.html

Related Reports:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/north-america-bicomponent-fiber-industry-situation-and-prospects-research-report/146380-101.html

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/china-bicomponent-fiber-industry-situation-and-prospects-research-report/146212-101.html

Contact:         

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-124-4230204

Singapore Medical Devices Market Outlook to 2022 : Ken Research

The report titled “Singapore Medical Devices Market Outlook to 2022 - by Type of Medical Device (Consumables, Diagnostic Imaging, Patient Aids, Orthopedic & Prosthetics, Dental Products and Others)” covers aspects such as medical device market segment (by type of medical device, and by end users), competitive landscape of major players in the Singapore medical device market, and covering competitive landscape of major medical device manufacturers and distributors including QT Vascular, Biosensors International, Becton Dickinson, Optimal Medical Products Pte Ltd, B. Braun Singapore Pte Ltd, Alcare Pharmaceuticals, and Kingston Medical Supplies Pte Ltd. The report concludes with market projection for future highlighting the major opportunities and cautions.

Singapore Medical Device Market Overview

Singapore Medical device revenue increased at a double digit CAGR during 2012-2017.  The market is in the growing stage with rise in number of foreign players. This was driven by expansion of healthcare institutions and increased demand for home care devices such as Elderly Care -Monitoring Systems (sensors at home, applications, and wearable devices). Singaporeans’ strong demand for better healthcare creates an excellent market for foreign medical device companies, who supply more than 85% of the country’s devices. Leading importers include the US, Germany and Japan. At present, more than 60% of products imported into Singapore are subsequently re-exported.

Singapore Medical Device Market Segmentation

By type of Medical Device: Consumables have accounted for the largest share in terms of revenues in Singapore Medical Devices market in 2017. This is followed by diagnostic imaging products, patient’s aids, orthopedic & prosthetics and dental products. Others which include Point of Care Testing devices, radiation oncology devices, therapy system and testing and measurement systems have accounted for remaining share of the overall market revenue.

By End Users: Ministry of Health which controls most of the hospitals and significant proportion of the clinics in Singapore has accounted for largest share of the medical devices in Singapore in 2017. Other healthcare institutions such as private hospitals and clinical laboratories have accounted for the remaining share.

Competitive Landscape of Singapore Medical Device Market

The medical device market in Singapore is fragmented with increasing focus on providing medical products, services and data intelligence services to its end users (public hospitals, private hospitals and others) to aid in delivering high quality care in a cost effective way to their patients. Market players are competing on product customization and technology. Domestic manufacturers focus on consumables and foreign players focus on high-end devices. International players have started to focus on new consumer centric models such as e-commerce, home health care, and DIY health concepts. Major companies include QT Vascular, Biosensors International, Becton Dickinson, Optimal Medical Products Pte Ltd, B. Braun Singapore Pte Ltd, Alcare Pharmaceuticals, and Kingston Medical Supplies Pte Ltd

Singapore Medical Devices Market Future Potential

The market is estimated to register single digit CAGR growth during 2017-2022. Digitalization is a key trend in healthcare with the electronic patient record in place and improving communication systems are being considered. Telehealth and remote monitoring are being trialed for future implementation. There is also a shift from treatment to preventive care and health promotion, where mobile applications and wearable devices or the Internet of Things will see an increased uptake. The opportunities are in personal health management, health screening, disease management, preventive care products, access to homecare resources and support, health IT solutions, data sharing, and advanced technologies that would enable integrated healthcare

To know more, click on the link below:

https://www.kenresearch.com/healthcare/medical-devices/singapore-medical-equipment-market/149667-91.html

Related Report  : -

https://www.kenresearch.com/healthcare/general-healthcare/uae-healthcare-market-report/37505-91.html

https://www.kenresearch.com/healthcare/general-healthcare/qatar-healthcare-market-report/99730-91.html

https://www.kenresearch.com/healthcare/general-healthcare/saudi-arabia-healthcare-market-research-report/1106-91.html

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Telemedicine: Giant Leap For Healthcare Market Outlook-Ken Research

Healthcare sector has become of the world’s largest sector- both in terms of revenue and employment. Healthcare industry comprises of providers of diagnostic, preventive, remedial, and therapeutic services such as doctors, nurses, hospital, medical devices and equipments, clinical trials, telemedicine, medical tourism, health insurance and pharmaceutical manufacturers. Medicine plays a very important role in protecting, restoring and maintaining one’s life so it is prerequisite to have adequate quantity and superior quality at a reasonable rate therefore has become concern of global and national policy makers to fulfill the needs. Especially in rural or undeveloped parts of the country it has become necessary to initiate a system that could provide specialized pocket friendly medication. Health Care Market Research Reports state that Telemedicine solved the issue as it used telecommunication and information technology to deliver healthcare services where distance and inadequate infrastructure act as a barrier.

Over these years Telemedicine has transformed into complex integrated service used in homes, hospitals and private clinics. Healthcare has grown immensely since telemedicine injection because of its phenomenal characteristic to respond to medical emergencies by sharing expertise medical consultation and patient health records without delay in remote areas as well as urban. Telepsychiatry is one of the leading fields in Telemedicine as it brings expertise psychological treatment to patients remotely by experienced psychiatrist to their door step. There is quickly and timely follow up of patients along with maintaining their computerized comprehensive data. The modes of Telepsychiatry communication are:

Ø  Synchronous-mimic face to face

Ø  Asynchronous-non real time, store and forward

Ø  Through cell phones, mails, online chats, blogs etc

Telepsychiatry works in a setting where there is either just patient or psychiatrist interact virtually or in present of family or under surveillance of some other psychiatrist so that patient is safe and don’t harm him. Telepsychiatry deals with the treatment of depression disorders, panic disorders, agoraphobia, and social phobia and anxiety issues. It gives shy patient sense of confidence and comfort level without exposing that they are seeking psychological help which let them express their psychological state without any fear of being judged. Health Care Industry Analysis states positive outcome in terms of acceptability and satisfaction of this type of medication which is of reasonable cost as well as reliable. There are many institution and hospital supporting telepsychiatry for example in India it is actively supported by Apollo Hospital, cherry on the cake where south India involved mobile telepsychiatry unit with video-conferencing facility to cater one district and In America JSA health Telepsychiatry has been initiated.

Most Tele Psychiatry projects have been reported from the developed nation like America, Australia, Canada and certain Europe Countries. In developing countries like India is at its preliminary stage. Telepsychiatry holds the potential to solve the enormous and intertwined problems of under diagnosing and under treating persons with mental illness and the lack of trained manpower at grassroots level. With the growth in practice of Telepsychiatry it is expected to become more diagnostically reliable, efficient and cost effective according to the needs and resources of developed nation. Telepsychiatry has become feasible alternative for the existing and grossly scarce mental health services.

To know more, click on the link below:

https://www.kenresearch.com/healthcare/general-healthcare/SC-91-64.html

Related Report:

https://www.kenresearch.com/healthcare/general-healthcare/healthcare-robotics-market-analysis-segment-forecast/144739-91.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249